Guardian Investment Management Abbott Laboratories Transaction History

Guardian Investment Management

$125 Million
Q3 2024

A detailed history of Guardian Investment Management transactions in Abbott Laboratories stock. As of the latest transaction made, Guardian Investment Management holds 11,582 shares of ABT stock, worth $1.38 Million. This represents 1.06% of its overall portfolio holdings.

Number of Shares

11,582

Previous 11,525 0.49%

Holding current value

$1.38 Million

Previous $1.2 Million 10.28%

% of portfolio

1.06%

Previous 0.82%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 10, 2024	BUY	$100.07 - $118.13 $5,703 - $6,733	57 Added 0.49%	11,582 $1.32 Million
Q2 2024 Jul 23, 2024	SELL	$100.73 - $112.44 $90,657 - $101,196	-900 Reduced 7.24%	11,525 $1.2 Million
Q1 2024 Apr 26, 2024	SELL	$109.52 - $120.96 $35,594 - $39,312	-325 Reduced 2.55%	12,425 $1.41 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $18,038 - $22,080	-200 Reduced 1.54%	12,750 $1.4 Million
Q3 2023 Oct 13, 2023	SELL	$95.53 - $114.62 $4,776 - $5,731	-50 Reduced 0.38%	12,950 $1.25 Million
Q2 2023 Jul 14, 2023	SELL	$100.78 - $112.29 $82,337 - $91,740	-817 Reduced 5.91%	13,000 $1.42 Million
Q1 2023 May 05, 2023	BUY	$96.86 - $114.01 $42,037 - $49,480	434 Added 3.24%	13,817 $1.4 Million
Q4 2022 Jan 12, 2023	SELL	$95.06 - $111.52 $3,136 - $3,680	-33 Reduced 0.25%	13,383 $0
Q3 2022 Oct 12, 2022	SELL	$96.76 - $112.03 $967 - $1,120	-10 Reduced 0.07%	13,416 $1.3 Million
Q4 2021 Jan 19, 2022	BUY	$115.53 - $141.46 $1,039 - $1,273	9 Added 0.07%	13,426 $1.89 Million
Q2 2021 Jul 14, 2021	SELL	$105.79 - $124.53 $42,316 - $49,812	-400 Reduced 2.89%	13,417 $1.56 Million
Q2 2020 Jul 13, 2020	SELL	$76.57 - $98.0 $51,608 - $66,052	-674 Reduced 4.65%	13,817 $1.26 Million
Q1 2020 May 07, 2020	SELL	$62.82 - $91.86 $69,102 - $101,046	-1,100 Reduced 7.06%	14,491 $1.12 Million
Q2 2019 Aug 16, 2019	BUY	$72.88 - $85.0 $43,728 - $51,000	600 Added 4.0%	15,591 $1.31 Million
Q1 2019 Apr 22, 2019	SELL	$66.22 - $80.06 $445,859 - $539,043	-6,733 Reduced 30.99%	14,991 $1.2 Million
Q4 2018 Feb 06, 2019	BUY	$65.56 - $74.27 $8,719 - $9,877	133 Added 0.62%	21,724 $1.57 Million
Q3 2018 Oct 19, 2018	SELL	$60.81 - $73.36 $60,810 - $73,360	-1,000 Reduced 4.43%	21,591 $1.58 Million
Q2 2018 Jul 13, 2018	SELL	$57.57 - $63.54 $5,757 - $6,354	-100 Reduced 0.44%	22,591 $1.38 Million
Q1 2018 May 11, 2018	BUY	$56.27 - $63.62 $52,612 - $59,484	935 Added 4.3%	22,691 $1.35 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $380,591 - $407,462	7,090 Added 48.34%	21,756 $1.24 Million
Q3 2017 Oct 19, 2017	BUY	$48.06 - $53.64 $704,847 - $786,684	14,666	14,666 $782,000

Others Institutions Holding ABT

# of Institutions

3,185

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.

Account

Guardian Investment Management Abbott Laboratories Transaction History